Open access

ISSN: 2950-5755

Wu, Fenfang

Editorial Board Members, Regenesis Repair Rehabilitation

Shenzhen Third People's Hospital, Shenzhen, China

Shenzhen Third People's Hospital, Shenzhen, China

Wu Fenfang, Ph.D., postdoctoral fellow, researcher, doctoral supervisor, postdoctoral supervisor, Shenzhen Distinguished Talent (Category B), and senior visiting scholar at the University of Denver (USA). Experience includes working at Sun Yat-sen University, Guangzhou Institutes of Biomedicine and Health (Chinese Academy of Sciences), and Shenzhen Hospital of Beijing University of Chinese Medicine. Currently serves as Director of the Center for Biotherapy at Shenzhen Third People’s Hospital, Director of the Innovation and Immune Regeneration Key Laboratory of Traditional Chinese Medicine in Longgang District, Shenzhen, and Chief Researcher at the Center for Cell and Gene Therapy, Southern University of Science and Technology. Additional roles include Vice Chair of Guangdong Society for Immune and Stem Cell Therapy, expert in the Expert Database of the Ministry of Science and Technology of China, reviewer for the National Natural Science Foundation of China, and science and technology reviewer for Guangdong, Jiangsu, and Shenzhen. Also serves as senior professional title reviewer in Shenzhen, editorial board member of AJPS, and editorial board member of the Chinese Journal of Cell and Stem Cell. Led multiple national and provincial research projects. Authored over 60 SCI papers in journals such as Journal of Hepatology, Cell Discovery, and Annals of Oncology. Recipient of the First Prize of the Provincial Natural Science Academic Achievement Award, the First and Third Prizes of the Provincial Science and Technology Award, the Second Prize of the Scientific and Technological Award of the Chinese Association of Chinese Medicine, and the Third Prize of the Military Science and Technology Progress Award.Granted 16 national invention patents and 1 international PCT patent, with four patents successfully commercialized, each achieving a transfer value of over RMB 10 million.

Stay Informed

Register your interest and receive email alerts tailored to your needs. Sign up below.